<?xml version="1.0" encoding="UTF-8"?>
<NDC>
<NDCCode>
75934-0004-2
</NDCCode>
<PackageDescription>
.9 g in 1 PACKAGE (75934-0004-2)
</PackageDescription>
<NDC11Code>
75934-0004-02
</NDC11Code>
<ProductNDC>
75934-0004
</ProductNDC>
<ProductTypeName>
HUMAN OTC DRUG
</ProductTypeName>
<ProprietaryName>
Triple Antibiotic
</ProprietaryName>
<ProprietaryNameSuffix/>
<NonProprietaryName>
Neomycin Sulfate
</NonProprietaryName>
<DosageFormName>
OINTMENT
</DosageFormName>
<RouteName>
TOPICAL
</RouteName>
<StartMarketingDate>
20120101
</StartMarketingDate>
<EndMarketingDate/>
<MarketingCategoryName>
OTC MONOGRAPH FINAL
</MarketingCategoryName>
<ApplicationNumber>
part333B
</ApplicationNumber>
<LabelerName>
Tiger Medical Group (US), Inc.
</LabelerName>
<SubstanceName>
BACITRACIN; NEOMYCIN SULFATE; POLYMYXIN B SULFATE
</SubstanceName>
<StrengthNumber>
400; 3.5; 5000
</StrengthNumber>
<StrengthUnit>
[iU]/g; mg/g; [iU]/g
</StrengthUnit>
<Pharm_Classes/>
<DEASchedule/>
<Status>
Deprecated
</Status>
<LastUpdate>
2014-05-05
</LastUpdate>
<PackageNdcExcludeFlag/>
<ProductNdcExcludeFlag/>
<ListingRecordCertifiedThrough/>
<StartMarketingDatePackage/>
<EndMarketingDatePackage/>
<SamplePackage/>
</NDC>